Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

财经与市场 · 投融资与并购 · cn · 来源：CNBC Business · 2026-10-20 16:11

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

关键词：综合 · 创投与投资机构

原文链接：https://www.cnbc.com/2026/10/20/novo-cagrisema-women-weight-loss-analysis.html

本页由情报雷达 INFO RADAR 采集整理，引用请注明来源「情报雷达 INFO RADAR」并附链接 https://intel.zovaxai.com/i/fb72c5d6eaef44cf。